Egalet
Egalet is a specialty pharmaceutical company that develops and markets medicines for patients with acute and chronic pain. The company utilizes its proprietary Guardian Technology to create treatments with chemical and physical properties designed to resist common methods of opioid abuse. Its manufacturing process is the first to combine injection molding with pharmaceutical production for orally delivered products.
Visit websiteWayne, United States
Healthtech
Pharmaceuticals
Biotechnology
Funding summary
- Total raised
- €22.1M
- Funding rounds
- 2
Investors in Egalet
Investors on record for Egalet. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Egalet?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors